Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery

计划入组 100 人 · 首次发布于 2017 年 9 月 12 日

Sacral Neuromodulation & Urodynamics

计划入组 100 人 · 首次发布于 2018 年 8 月 3 日

Sacral Neuromodulation and the Microbiome

计划入组 50 人 · 首次发布于 2016 年 7 月 14 日

CAR T-cell therapy (sacral tumor)

Cabral

botulinum neuromodulator (Macular Degeneration)

Axonics

United States

ANM Adaptive Neuromodulation GmbH

Germany

LivaNova

United Kingdom

FDA Approves First Integrated Sacral Neuromodulation System for Urinary Urge Incontinence

Battery-Free Sacral Neuromodulation Device Shows 84% Success Rate in Treating Urinary Incontinence

Axonics R20 Sacral Neuromodulation System Gains Australian Regulatory Approval